hero image
Glenn Knox - University of Florida. Gainesville, FL, US

Glenn Knox

Clinical Associate Professor | University of Florida

Gainesville, FL, UNITED STATES

Dr. Knox is a double board-certified ear surgeon and trained expert witness with over 40 years of experience treating ear related disorders


Dr. Glenn Knox is a double board-certified ear surgeon and trained expert witness with over 40 years of experience treating and operating on ear, balance, and hearing conditions. He has expertise in all common otolaryngologic disorders with a special interest in tinnitus, cholesteatoma, hearing loss, dizziness, and facial paralysis. Currently, he is a clinical associate professor in the Department of Pathology, Immunology, and Laboratory Medicine at the University of Florida, aiding in the development of antiviral therapies.

Areas of Expertise (9)

Brain Injury


Ear Infections

Hearing Loss

Ear Injury





Media Appearances (1)

UF Health researcher mapped omicron variant's mutations: Here's what he found

The Gainesville Sun  online


A University of Florida Health researcher has successfully analyzed the many mutations in the omicron variant of the SARS-CoV-2 virus, a crucial step in better understanding the variant’s potential threat and ways to combat it. Immunologist David A. Ostrov was asked by a worldwide consortium of scientists to analyze and map the locations of omicron’s mutations. His analysis for the Global Virus Network found omicron has substantially more mutations than the delta variant at four key sites within the virus.

view more


Articles (1)

Emerging mutation patterns in SARS-CoV-2 variants

Biochemical and Biophysical Research Communications

David A. Ostrov, Glenn W. Knox


There is an urgent need to understand the functional effects of mutations in emerging variants of SARS-CoV-2. Variants of concern (alpha, beta, gamma and delta) acquired four patterns of spike glycoprotein mutations that enhance transmissibility and immune evasion: 1) mutations in the N-terminal domain (NTD), 2) mutations in the Receptor Binding Domain (RBD), 3) mutations at interchain contacts of the spike trimer, and 4) furin cleavage site mutations.

view more





loading image